Illumina launches innovative platform, stock rises
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 02 2023
0mins
Should l Buy ILMN?
Source: globenewswire
Illumina Inc. saw a price increase of 3.47%, reaching a 20-day high amid positive market conditions, with the Nasdaq-100 up 0.83% and the S&P 500 up 0.58%.
This surge is attributed to the launch of Illumina's Connected Multiomics platform, which integrates multiomic data to accelerate biological research. The platform's user-friendly design, based on feedback from early access users, allows researchers to easily analyze complex biological data, enhancing the efficiency of discoveries in precision medicine. The incorporation of AI capabilities further drives breakthroughs in biology and drug development.
The introduction of this innovative platform positions Illumina favorably in the competitive landscape of biological research tools, potentially leading to increased adoption and revenue growth as researchers seek advanced solutions for their studies.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ILMN?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ILMN
Wall Street analysts forecast ILMN stock price to rise
13 Analyst Rating
4 Buy
6 Hold
3 Sell
Hold
Current: 116.510
Low
40.50
Averages
133.54
High
170.00
Current: 116.510
Low
40.50
Averages
133.54
High
170.00
About ILMN
Illumina, Inc. is engaged in providing sequencing-and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets, enabling the adoption of genomic solutions in research and clinical settings. Its DNA sequencing technology is based on its reversible terminator-based sequencing chemistry, referred to as sequencing by synthesis biochemistry. Its BeadArray technology combines microscopic beads and a substrate in a manufacturing process to produce arrays that can perform many assays simultaneously. Its sequencing applications include whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which can sequence exomes, specific genes, RNA or other genomic regions of interest. Its customers include genomic research centers, academic institutions, government laboratories, hospitals, pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Illumina Management to Participate in Investor Conference
- Investor Conference Schedule: Illumina will hold an investor conference at 12:10 PM PT (3:10 PM ET), where management will participate in discussions, likely attracting investor interest and enhancing company transparency.
- Webcast Availability: The conference will be accessible via a live webcast on Illumina's website, allowing global investors to participate in real-time and obtain the latest information, with a replay available for at least 30 days post-event.
- Company Background: Illumina focuses on innovation in genomics and has established itself as a global leader in DNA sequencing and array technologies, with products widely used in life sciences, oncology, reproductive health, and other emerging fields, showcasing its strong influence in the biotech industry.
- Multi-Channel Engagement: Illumina encourages investors to connect through its social media platforms (such as X, Facebook, LinkedIn, etc.), enhancing interaction with investors and increasing brand awareness and market impact.
See More
Illumina to Participate in Investor Conference
- Investor Conference Announcement: Illumina will participate in the TD Cowen 46th Annual Health Care Conference on March 3, 2026, where members of its management team will speak, highlighting the company's leadership in genomics.
- Webcast Details: The fireside chat is scheduled for 12:10 PM PT (3:10 PM ET), and investors can access the live stream through the Events & Presentations section of Illumina's website, ensuring broad dissemination of information.
- Replay Availability: A replay of the event will be archived on Illumina's website for at least 30 days post-event, allowing investors who cannot attend live to access key insights, thereby enhancing communication between the company and its investors.
- Company Overview: Illumina focuses on innovation in genomic technologies aimed at improving human health, with products widely used in life sciences, oncology, and reproductive health, further solidifying its leadership position in the global market.
See More
AI Drives Transformation in Genomics and Biological Manufacturing
- Genomics Advancement: Illumina secures U.S. Medicare reimbursement for its TruSight™ Oncology Comprehensive test, expected to significantly enhance the generation of clinically relevant genomic data, thereby advancing routine genomic profiling in cancer care.
- Liquid Biopsy Expansion: Guardant Health expands the availability of its Shield™ colorectal cancer screening test to U.S. military personnel and their families, enhancing the foundational data generation for precision medicine through ctDNA analysis.
- Drug Discovery Innovation: Recursion Pharmaceuticals leverages AI and machine learning to accelerate drug discovery, emphasizing platform scalability to reduce development time and costs, while attracting institutional interest from firms like ARK Investment Management.
- Spider Silk Production Plan: Kraig Biocraft Laboratories plans large-scale deployment of its transgenic silkworm platform in 2026, aiming to achieve a production capacity of 10 metric tons of recombinant spider silk per month by May, potentially opening new markets for high-performance materials.
See More
US Stocks Surge, Dow Hits All-Time High
- Dow Hits Record High: The Dow Jones Industrial Average surged 2.47% to reach an all-time high, reflecting market optimism about economic recovery, particularly amid strong rebounds in tech and chipmaker stocks.
- Consumer Confidence Rises: The University of Michigan's consumer sentiment index unexpectedly increased to 57.3, surpassing expectations of 55.0, indicating enhanced consumer confidence that could drive future spending.
- Bitcoin Rebounds: Bitcoin surged over 11% from a 1.25-year low, lifting cryptocurrency-exposed stocks and signaling renewed investor interest and confidence in crypto assets.
- Strong Corporate Earnings: Over 79% of S&P 500 companies exceeded earnings expectations, with S&P earnings growth projected at 8.4% for Q4, providing robust support for the market and indicating ongoing improvement in corporate profitability.
See More
U.S. Stocks Surge as Tech Earnings Boost Market Sentiment
- Market Performance: The S&P 500 Index rose by 1.10%, and the Dow Jones Industrial Average increased by 1.60%, reaching an all-time high, reflecting positive market sentiment driven by strong tech earnings results.
- Tech Stock Recovery: Gen Digital and Roblox surged over 7% and 9%, respectively, after forecasting full-year adjusted EPS and bookings above consensus, indicating a robust recovery in the tech sector that may attract more investment.
- Consumer Confidence Boost: The University of Michigan's consumer sentiment index unexpectedly rose to 57.3, a six-month high, surpassing expectations of 55.0, reflecting optimistic consumer sentiment about the economic outlook, which supports further market gains.
- Inflation Expectations Shift: While short-term inflation expectations fell, long-term expectations ticked up slightly, indicating market concerns regarding the Fed's monetary policy, which could influence future investment decisions and market volatility.
See More
U.S. Stocks Surge as Tech Earnings Boost Market Sentiment
- Tech Stock Rebound: The S&P 500 rose by 1.20% and the Dow Jones Industrial Average surged by 1.48%, reaching an all-time high, driven by better-than-expected tech earnings that boosted investor confidence in the sector's recovery.
- Bitcoin Recovery: Bitcoin rebounded over 7% from a 1.25-year low, lifting cryptocurrency-exposed stocks and alleviating concerns about liquidity in the crypto market, indicating renewed investor interest in digital assets.
- Amazon Investment Concerns: Amazon's announcement of a $200 billion investment in data centers, chips, and other equipment led to a more than 9% drop in its stock, raising doubts about the long-term returns of its AI investments and potentially impacting future investor confidence.
- Earnings Season Insights: With 79% of S&P 500 companies exceeding expectations and Q4 earnings projected to grow by 8.4%, this indicates strong corporate profitability, which may provide ongoing support for the market despite economic uncertainties.
See More
Illumina Management to Participate in Investor Conference
- Investor Conference Schedule: Illumina will hold an investor conference at 12:10 PM PT (3:10 PM ET), where management will participate in discussions, likely attracting investor interest and enhancing company transparency.
- Webcast Availability: The conference will be accessible via a live webcast on Illumina's website, allowing global investors to participate in real-time and obtain the latest information, with a replay available for at least 30 days post-event.
- Company Background: Illumina focuses on innovation in genomics and has established itself as a global leader in DNA sequencing and array technologies, with products widely used in life sciences, oncology, reproductive health, and other emerging fields, showcasing its strong influence in the biotech industry.
- Multi-Channel Engagement: Illumina encourages investors to connect through its social media platforms (such as X, Facebook, LinkedIn, etc.), enhancing interaction with investors and increasing brand awareness and market impact.
See More
Illumina to Participate in Investor Conference
- Investor Conference Announcement: Illumina will participate in the TD Cowen 46th Annual Health Care Conference on March 3, 2026, where members of its management team will speak, highlighting the company's leadership in genomics.
- Webcast Details: The fireside chat is scheduled for 12:10 PM PT (3:10 PM ET), and investors can access the live stream through the Events & Presentations section of Illumina's website, ensuring broad dissemination of information.
- Replay Availability: A replay of the event will be archived on Illumina's website for at least 30 days post-event, allowing investors who cannot attend live to access key insights, thereby enhancing communication between the company and its investors.
- Company Overview: Illumina focuses on innovation in genomic technologies aimed at improving human health, with products widely used in life sciences, oncology, and reproductive health, further solidifying its leadership position in the global market.
See More
AI Drives Transformation in Genomics and Biological Manufacturing
- Genomics Advancement: Illumina secures U.S. Medicare reimbursement for its TruSight™ Oncology Comprehensive test, expected to significantly enhance the generation of clinically relevant genomic data, thereby advancing routine genomic profiling in cancer care.
- Liquid Biopsy Expansion: Guardant Health expands the availability of its Shield™ colorectal cancer screening test to U.S. military personnel and their families, enhancing the foundational data generation for precision medicine through ctDNA analysis.
- Drug Discovery Innovation: Recursion Pharmaceuticals leverages AI and machine learning to accelerate drug discovery, emphasizing platform scalability to reduce development time and costs, while attracting institutional interest from firms like ARK Investment Management.
- Spider Silk Production Plan: Kraig Biocraft Laboratories plans large-scale deployment of its transgenic silkworm platform in 2026, aiming to achieve a production capacity of 10 metric tons of recombinant spider silk per month by May, potentially opening new markets for high-performance materials.
See More
US Stocks Surge, Dow Hits All-Time High
- Dow Hits Record High: The Dow Jones Industrial Average surged 2.47% to reach an all-time high, reflecting market optimism about economic recovery, particularly amid strong rebounds in tech and chipmaker stocks.
- Consumer Confidence Rises: The University of Michigan's consumer sentiment index unexpectedly increased to 57.3, surpassing expectations of 55.0, indicating enhanced consumer confidence that could drive future spending.
- Bitcoin Rebounds: Bitcoin surged over 11% from a 1.25-year low, lifting cryptocurrency-exposed stocks and signaling renewed investor interest and confidence in crypto assets.
- Strong Corporate Earnings: Over 79% of S&P 500 companies exceeded earnings expectations, with S&P earnings growth projected at 8.4% for Q4, providing robust support for the market and indicating ongoing improvement in corporate profitability.
See More
U.S. Stocks Surge as Tech Earnings Boost Market Sentiment
- Market Performance: The S&P 500 Index rose by 1.10%, and the Dow Jones Industrial Average increased by 1.60%, reaching an all-time high, reflecting positive market sentiment driven by strong tech earnings results.
- Tech Stock Recovery: Gen Digital and Roblox surged over 7% and 9%, respectively, after forecasting full-year adjusted EPS and bookings above consensus, indicating a robust recovery in the tech sector that may attract more investment.
- Consumer Confidence Boost: The University of Michigan's consumer sentiment index unexpectedly rose to 57.3, a six-month high, surpassing expectations of 55.0, reflecting optimistic consumer sentiment about the economic outlook, which supports further market gains.
- Inflation Expectations Shift: While short-term inflation expectations fell, long-term expectations ticked up slightly, indicating market concerns regarding the Fed's monetary policy, which could influence future investment decisions and market volatility.
See More
U.S. Stocks Surge as Tech Earnings Boost Market Sentiment
- Tech Stock Rebound: The S&P 500 rose by 1.20% and the Dow Jones Industrial Average surged by 1.48%, reaching an all-time high, driven by better-than-expected tech earnings that boosted investor confidence in the sector's recovery.
- Bitcoin Recovery: Bitcoin rebounded over 7% from a 1.25-year low, lifting cryptocurrency-exposed stocks and alleviating concerns about liquidity in the crypto market, indicating renewed investor interest in digital assets.
- Amazon Investment Concerns: Amazon's announcement of a $200 billion investment in data centers, chips, and other equipment led to a more than 9% drop in its stock, raising doubts about the long-term returns of its AI investments and potentially impacting future investor confidence.
- Earnings Season Insights: With 79% of S&P 500 companies exceeding expectations and Q4 earnings projected to grow by 8.4%, this indicates strong corporate profitability, which may provide ongoing support for the market despite economic uncertainties.
See More
